DK0584247T3 - Sammensætninger til behandling af kronisk træthedssyndrom - Google Patents

Sammensætninger til behandling af kronisk træthedssyndrom

Info

Publication number
DK0584247T3
DK0584247T3 DK92912694T DK92912694T DK0584247T3 DK 0584247 T3 DK0584247 T3 DK 0584247T3 DK 92912694 T DK92912694 T DK 92912694T DK 92912694 T DK92912694 T DK 92912694T DK 0584247 T3 DK0584247 T3 DK 0584247T3
Authority
DK
Denmark
Prior art keywords
compositions
treatment
chronic fatigue
fatigue syndrome
syndrome
Prior art date
Application number
DK92912694T
Other languages
Danish (da)
English (en)
Inventor
Thomas Peter Bridge
Frederick K Goodwin
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0584247T3 publication Critical patent/DK0584247T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92912694T 1991-05-08 1992-05-08 Sammensætninger til behandling af kronisk træthedssyndrom DK0584247T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/696,556 US5189022A (en) 1988-05-27 1991-05-08 Composition for the treatment of chronic fatigue syndrome
PCT/US1992/003582 WO1992019257A1 (en) 1991-05-08 1992-05-08 Compositons for the treatment of chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
DK0584247T3 true DK0584247T3 (da) 2000-11-06

Family

ID=24797555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912694T DK0584247T3 (da) 1991-05-08 1992-05-08 Sammensætninger til behandling af kronisk træthedssyndrom

Country Status (10)

Country Link
US (1) US5189022A (de)
EP (1) EP0584247B1 (de)
JP (1) JP3215110B2 (de)
AU (1) AU663875B2 (de)
CA (1) CA2102606C (de)
DE (1) DE69231384T2 (de)
DK (1) DK0584247T3 (de)
ES (1) ES2149177T3 (de)
GR (1) GR3034757T3 (de)
WO (1) WO1992019257A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
ATE194495T1 (de) * 1992-03-27 2000-07-15 Advanced Immunit T Inc T-peptid und damit verwandte peptide in der behandlung von entzündungen einschliesslich der multiplen sklerose
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
ES2220915T3 (es) 1993-09-24 2004-12-16 Advanced Immuni T, Inc. Peptidos lineales y ciclicos para el tratamiento o prevencion de la enfermedad de crohn y/o colitis ulcerosa.
DE69433763T2 (de) * 1993-09-24 2005-04-14 Advanced Immuni T, Inc. Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
NZ591825A (en) * 2005-07-26 2012-10-26 Cms Peptides Patent Holding Company Ltd Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating fatigue
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
US5013739A (en) * 1986-10-07 1991-05-07 Bernard Bihari Method of treating chronic fatigue syndrome using an opiate receptor antagonist
US5063206A (en) * 1988-12-16 1991-11-05 The United States Of Americas As Represented By The Department Of Health And Human Services Compositions having use as treatment of neuropsychiatric deficits
WO1989012067A1 (en) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Compositions having use as treatment of psoriasis and neuropsychiatric deficits

Also Published As

Publication number Publication date
JPH06510749A (ja) 1994-12-01
CA2102606C (en) 2003-02-11
EP0584247A4 (en) 1994-09-14
EP0584247B1 (de) 2000-08-23
ES2149177T3 (es) 2000-11-01
US5189022A (en) 1993-02-23
JP3215110B2 (ja) 2001-10-02
WO1992019257A1 (en) 1992-11-12
DE69231384T2 (de) 2001-02-01
CA2102606A1 (en) 1992-11-09
AU663875B2 (en) 1995-10-26
GR3034757T3 (en) 2001-02-28
EP0584247A1 (de) 1994-03-02
DE69231384D1 (de) 2000-09-28
AU2015292A (en) 1992-12-21

Similar Documents

Publication Publication Date Title
DE69411795D1 (de) Bauelemente
FI951413A7 (fi) Pintakäsittelykoostumus
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
FI921598A0 (fi) Transdermal komposition.
DE59206807D1 (de) Modifizierte chromatographische Trägermaterialien
DE69310839D1 (de) Fungiresistente Polyorganosiloxanzusammensetzung
FI933467A7 (fi) Koostumus
DK0584247T3 (da) Sammensætninger til behandling af kronisk træthedssyndrom
DE69230463D1 (de) Ozonfreundliche korrekturflüssigkeit
NO942305L (no) Belegningsmaterialer
FI922688A0 (fi) Komposition foer uppfriskning av luft.
DE69227976D1 (de) Amphotere Zusammensetzungen
FI924643A7 (fi) Braenslekomposition
DE69213566D1 (de) Transientenunterdrückendes Bauteil
DE69222233D1 (de) Halogen Scavenger Zusammensetzung
DE69327812D1 (de) Arsen-enthaltende arzneimittel zur behandlung des chronischen ermüdungssyndroms
DE69207876D1 (de) Bauelement
DK0951289T3 (da) Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
FI923849L (fi) Rengoeringskompositioner
DE69201298D1 (de) Klebemittelzusammensetzungen.
FI925827L (fi) Tvaerbindbar polymerisk komposition
DE69225266D1 (de) Bis-bibenzimidazol Zusammensetzung
BR9202742A (pt) Composicao delimpeza
FI925175A0 (fi) Kompositioner haerdbara medelst straolning